Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
European Journal of Pharmacology|January 26, 2011
Pharmacological characterization of zinc and copper interaction with the human alpha(1A)-adrenoceptorJustyna Ciolek, Arhamatoulaye Maïga, Elodie Marcon, et al.Toxins|August 25, 2019
Evaluation of the Spider (Phlogiellus genus) Phlotoxin 1 and Synthetic Variants as Antinociceptive Drug CandidatesTânia C Gonçalves, Pierre Lesport, Sarah Kuylle, et al.Journal of Medicinal Chemistry|September 5, 2022
From a Cone Snail Toxin to a Competitive MC4R AntagonistSteve Reynaud, Suli-Anne Laurin, Justyna Ciolek, et al.Proceedings of the National Academy of Sciences of the United States of America|June 21, 2017
Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney diseaseJustyna Ciolek, Helen Reinfrank, Loïc Quinton, et al.British Journal of Pharmacology|February 5, 2022
A new Kunitz-type snake toxin family associated with an original mode of interaction with the vasopressin 2 receptorLaura Droctové, Justyna Ciolek, Christiane Mendre, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
MT9, a natural peptide from black mamba venom antagonizes the muscarinic type 2 receptor and reverses the M2R-agonist-induced relaxation in rat and human arteriesJustyna Ciolek, Claude Zoukimian, Justine Dhot, et al.Journal of Medicinal Chemistry|July 1, 2020
A Venomics Approach Coupled to High-Throughput Toxin Production Strategies Identifies the First Venom-Derived Melanocortin Receptor AgonistsSteve Reynaud, Justyna Ciolek, Michel Degueldre, et al.Pageof 1